VARIATION OCCURRING IN GROUP A STREPTOCOCCI DURING HUMAN INFECTION
Open Access
- 31 May 1948
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 87 (6) , 521-533
- https://doi.org/10.1084/jem.87.6.521
Abstract
A study was made of the variation occurring in group A streptococci during the natural course of infection in man. From 54 patients with 56 different group A streptococcal infections of the upper respiratory tract, 251 strains of streptococci, isolated at weekly intervals following infection, were tested for their capacity to resist the bacteriostatic action of normal human blood. In 52 of the infections the streptococci were of recognized serological types and were also tested for variation in their ability to produce the type-specific M protein antigen. Strains isolated in the 1st week of infection were uniformly highly resistant to bacteriostasis and elaborated large amounts of M substance. In 42 per cent of the 52 infections, strains isolated in the convalescent and carrier stages showed an increasing susceptibility to bacteriostasis correlated with a progressive loss of M substance; whereas in the remaining 58 per cent resistance to bacteriostasis and the capacity to produce M protein were maintained throughout the observation period. In 3 different infections, the streptococci became so degraded that no M protein could be demonstrated in acid extracts of these variants. Concomitantly these strains became highly susceptible to bacteriostasis. Spontaneous reversion did not occur, but serial mouse passage reestablished these functions. These degraded variants had the same T antigen as their respective original strains. No evidence was obtained that variation of group A streptococci in resistance to bacteriostasis or in the ability to produce the type-specific M antigen was associated (a) with the appearance of type-specific bacteriostatic antibodies; (b) with any particular serological type of streptococcus; (c) with the production of streptococcal proteinase which digests the M protein; (d) with the therapeutic administration of sulfadiazine; or (e) with the development of complications. The possible relationship of these observations to the problem of the "dangerous carrier" of group A hemolytic streptococci is discussed.Keywords
This publication has 13 references indexed in Scilit:
- BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCIThe Journal of Experimental Medicine, 1945
- A PROTEOLYTIC ENZYME PRODUCED BY GROUP A STREPTOCOCCI WITH SPECIAL REFERENCE TO ITS EFFECT ON THE TYPE-SPECIFIC M ANTIGENThe Journal of Experimental Medicine, 1945
- TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTESThe Journal of Experimental Medicine, 1943
- TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCIThe Journal of Experimental Medicine, 1940
- ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCIThe Journal of Experimental Medicine, 1939
- STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGINThe Journal of Experimental Medicine, 1935
- A STUDY ON THE DISSOCIATION OF THE DIPHTHERIA BACILLUSJournal of Bacteriology, 1930
- VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXINThe Journal of Experimental Medicine, 1928
- ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTSThe Journal of Experimental Medicine, 1928
- THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HÆMOLYTICUSThe Journal of Experimental Medicine, 1928